POSSIBILITIES OF USING RUXOLITINIB TO IMPROVE THE RESULTS OF allo-HSCT (LITERATURE REVIEW). (2019). Voprosy Onkologii, 65(3), 330-336. https://doi.org/10.37469/0507-3758-2019-65-3-330-336